Skip To Main Content
Sort by

Filters

Reset
  • Therapeutical areas
REZUROCK (belumosudil) Tablets Mechanism of Action

REZUROCK (belumosudil) Tablets Mechanism of Action

Annual Risk Acknowledgement Form

Annual Risk Acknowledgement form

Revolutionizing Diabetes Management in India with Innovative Combination Injectable

Revolutionizing Diabetes Management in India with Innovative Combination Injectable

Transforming T2DM Management Paradigm with Combination Injectables

Transforming T2DM Management Paradigm with Combination Injectables

Advancing metrics and therapy in the card: using dTIR to assess outcomes for adults with Type 2 diabetes receiving an FRC

Advancing metrics and therapy in the card: using dTIR to assess outcomes for adults with Type 2 diabetes receiving an FRC

Effectiveness and saftey of iGlarLixi in adults with T2D- results from the real - world study CHANCE

Effectiveness and saftey of iGlarLixi in adults with T2D- results from the real - world study CHANCE

Treatment simplification in Type 2 diabetes: A less-is-more approach to reducing the burden of disease

Treatment simplification in Type 2 diabetes: A less-is-more approach to reducing the burden of disease

3 Reasons to Choose Toujeo

3 Reasons to Choose Toujeo

Optimizing Dosage with the Soliqua Solostar Pen: Tailored Guidance for Individual Patients

Optimizing Dosage with the Soliqua Solostar Pen: Tailored Guidance for Individual Patients

Soliqua: A Comprehensive Approach to Managing Type 2 Diabetes

Soliqua: A Comprehensive Approach to Managing Type 2 Diabetes

Maximum Mealtime Flexibility with Apidra®: A Leading Rapid Analogue

Maximum Mealtime Flexibility with Apidra®: A Leading Rapid Analogue

SEROGROUP A is responsible for majority of MENINGOCOCCAL MENINGITIS outbreaks in India¹

SEROGROUP A is responsible for majority of MENINGOCOCCAL MENINGITIS outbreaks in India¹